- Target
- EXOSC9
- Reactivity
- Human,Mouse,Rat
- Application
- WB
- MW(Calculated)
- 48kD
- MW(Observed)
- --
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:500-2000
- Form
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source
- --
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Clone No.
- --
- Immunogen
- Synthesized peptide derived from human EXOSC9
- Sequence
- --
- Specificity
- This antibody detects endogenous levels of EXOSC9 at Human, Mouse,Rat
- Gene Name
- EXOSC9 PMSCL1
- Protein Name
- Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75)
- Other Name
- --
- Organism-1
- Human
- Gene ID-1
- 5393
- SwissProt-1
- Q06265
- Organism-2
- Mouse
- Gene ID-2
- 50911
- SwissProt-2
- Q9JHI7
- Organism-3
- Rat
- Gene ID-3
- 294975
- SwissProt-3
- Q4QR75
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasm . Nucleus . Nucleus, nucleolus . Nucleus, nucleoplasm . Colocalizes with SETX in nuclear foci upon induction of transcription-related DNA damage at the S phase (PubMed:24105744). .; [Isoform 1]: Nucleus, nucleolus.; [Isoform 2]: Nucleus, nucleolus.; [Isoform 3]: Nucleus. Excluded from the nucleolus.